Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Leukemia

Free Subscription Articles published in Oncogene Retrieve available abstracts of 33 articles: HTML format

Single Articles

May 2022
1. GARZON R, Pichiorri F, Palumbo T, Visentini M, et al
   Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.
   Oncogene. 2022 May 11. pii: 10.1038/s41388-022-02351.
   PubMed    
   
   
   March 2022
2. WANG H, Zhang D, Cui X, Dai Y, et al
   Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
   Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02233.
   PubMed     Abstract available
   
   
   
3. CHEN TC, Yao CY, Chen YR, Yuan CT, et al
   Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.
   Oncogene. 2022;41:1576-1588.
   PubMed     Abstract available
   
   
   January 2022
4. FIDYT K, Pastorczak A, Cyran J, Crump NT, et al
   Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
   Oncogene. 2022 Jan 28. pii: 10.1038/s41388-022-02196.
   PubMed     Abstract available
   
   
   
5. MADRAZO E, Gonzalez-Novo R, Ortiz-Placin C, Garcia de Lacoba M, et al
   Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.
   Oncogene. 2022 Jan 8. pii: 10.1038/s41388-021-02168.
   PubMed     Abstract available
   
   
   December 2021
6. PAGE EC, Heatley SL, Eadie LN, McClure BJ, et al
   HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.
   Oncogene. 2021 Dec 2. pii: 10.1038/s41388-021-02126.
   PubMed     Abstract available
   
   
   October 2021
7. ZHANG J, Zhai J, Wong CC, Chen H, et al
   A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
   Oncogene. 2021 Oct 8. pii: 10.1038/s41388-021-01941.
   PubMed     Abstract available
   
   
   September 2021
8. HELTEMES-HARRIS LM, Hubbard GK, LaRue RS, Munro SA, et al
   Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
   Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02012.
   PubMed     Abstract available
   
   
   
9. WILHELM A, Marschalek R
   The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).
   Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02001.
   PubMed     Abstract available
   
   
   
10. REJESKI K, Duque-Afonso J, Lubbert M
    AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.
    Oncogene. 2021;40:5665-5676.
    PubMed     Abstract available
    
    
    August 2021
11. KUNDU A, Kowarz E, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11).
    Oncogene. 2021 Aug 5. pii: 10.1038/s41388-021-01983.
    PubMed     Abstract available
    
    
    
12. SCHWALBE EC, H L, Lafta F, Barrow TM, et al
    Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets.
    Oncogene. 2021;40:5213-5223.
    PubMed     Abstract available
    
    
    July 2021
13. KARUNANITHI S, Liu R, Hou Y, Gonzalez G, et al
    Thioredoxin reductase is a major regulator of metabolism in leukemia cells.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01924.
    PubMed     Abstract available
    
    
    June 2021
14. CHEN Z, Shao YL, Wang LL, Lin J, et al
    YTHDF2 is a potential target of AML1/ETO-HIF1alpha loop-mediated cell proliferation in t(8;21) AML.
    Oncogene. 2021;40:3786-3798.
    PubMed     Abstract available
    
    
    May 2021
15. YUSENKO MV, Trentmann A, Casolari DA, Abdel Ghani L, et al
    C/EBPbeta is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01800.
    PubMed     Abstract available
    
    
    April 2021
16. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    PubMed     Abstract available
    
    
    
17. WEI Y, Lu W, Yu Y, Zhai Y, et al
    miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
    Oncogene. 2021 Apr 22. pii: 10.1038/s41388-021-01775.
    PubMed     Abstract available
    
    
    
18. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available
    
    
    March 2021
19. BENCOMO-ALVAREZ AE, Rubio AJ, Olivas IM, Gonzalez MA, et al
    Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
    Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01732.
    PubMed     Abstract available
    
    
    January 2021
20. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    PubMed     Abstract available
    
    
    
21. OCHIIWA H, Ailiken G, Yokoyama M, Yamagata K, et al
    TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01586.
    PubMed     Abstract available
    
    
    November 2020
22. KOSCHUT D, Ray D, Li Z, Giarin E, et al
    RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia.
    Oncogene. 2020 Nov 27. pii: 10.1038/s41388-020-01567.
    PubMed     Abstract available
    
    
    
23. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    PubMed     Abstract available
    
    
    October 2020
24. CHU Y, Chen Y, Guo H, Li M, et al
    SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01495.
    PubMed     Abstract available
    
    
    September 2020
25. KARRA L, Romero-Moya D, Ksionda O, Krush M, et al
    Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01469.
    PubMed     Abstract available
    
    
    
26. BONGIOVANNI D, Tosello V, Saccomani V, Dalla Santa S, et al
    Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
    Oncogene. 2020 Sep 11. pii: 10.1038/s41388-020-01453.
    PubMed     Abstract available
    
    
    August 2020
27. TOTANI H, Shinjo K, Suzuki M, Katsushima K, et al
    Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.
    Oncogene. 2020 Aug 4. pii: 10.1038/s41388-020-01393.
    PubMed     Abstract available
    
    
    
28. BURGESS M, Chen YCE, Mapp S, Blumenthal A, et al
    HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.
    Oncogene. 2020;39:5756-5767.
    PubMed     Abstract available
    
    
    July 2020
29. TODA J, Ichii M, Oritani K, Shibayama H, et al
    Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
    Oncogene. 2020 Jul 13. pii: 10.1038/s41388-020-01387.
    PubMed     Abstract available
    
    
    June 2020
30. LIN CC, Yao CY, Hsu YC, Hou HA, et al
    Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Oncogene. 2020 Jun 12. pii: 10.1038/s41388-020-1340.
    PubMed     Abstract available
    
    
    April 2020
31. REDONDO MONTE E, Wilding A, Leubolt G, Kerbs P, et al
    ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene. 2020;39:3195-3205.
    PubMed     Abstract available
    
    
    February 2020
32. LOPEZ-GUERRA M, Xargay-Torrent S, Fuentes P, Roldan J, et al
    Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
    Oncogene. 2020;39:1185-1197.
    PubMed     Abstract available
    
    
    January 2020
33. WANG L, Zhao H, Li J, Xu Y, et al
    Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines.
    Oncogene. 2020;39:677-689.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: